Naloxone Oral Syringes
Cancelled Solicitation Posted
- Solicitation number
- W81K00-26-Q-A022
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command, specifically Brooke Army Medical Center (BAMC), is soliciting bids for 1,413 Naloxone 2mg/2mL oral syringes annually under a base plus four-year contract (five years total). The syringes must be packaged with tamper-evident caps, labeled for oral use only, without luer lock tips, and maintain a beyond-use date of at least 30 days. This procurement will utilize a Lowest Price Technically Acceptable (LPTA) source selection process, meaning the contract will be awarded to the responsible offeror with the lowest evaluated price that meets all technical specifications. The solicitation amendment (Amendment 0002) extended the deadline to October 28, 2025, at 3:00 p.m. MST for responses, with bidder questions having been due on October 17, 2025. The government reserves the right to conduct discussions with offerors if deemed necessary during the evaluation process.
This solicitation was initially set aside for Women-Owned Small Businesses (WOSB), though the current amendment indicates no set-aside is being used for full and open competition under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The contract will be performed at San Antonio, Texas 78234, with delivery required to support the inpatient pharmacy section at BAMC/Joint Base San Antonio Fort Sam Houston. Each contract line item requires delivery of 1,413 oral syringes annually, with option years extending through September 30, 2030, and a contract period beginning October 1, 2025. The procurement is being conducted using fixed pricing with funding through Operations & Maintenance, Army (OMA) and other Defense Health Program funds. No specific incumbent contractor or award value range is disclosed in the solicitation documents, though the contract represents a critical supply requirement for emergency opioid overdose treatment capabilities.
Notice text
THE PURPOSE OF SOLICITATION AMENDMENT 0002 IS TO EXTEND THE SOLICITATION TO 28 OCTOBER 2025 FOR THE NALOXONE 2MG/2ML ORAL SYRINGES.
The Department of Pharmacy at Brooke Army Medical Center (BAMC) is requesting a base plus 4 year (5 years total) contract for 1,413 Naloxone oral syringes annually.
Bidder Questions Due: 17 Oct 2025
Responses Due: 28 Oct 2025, 3:00 p.m., MST
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Naloxone Oral Syringes | Solicitation | |
| Naloxone Oral Syringes | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity